My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about SVB Leerink
Recent news which mentions SVB Leerink
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today
January 18, 2023
Tickers
GSK
JNJ
MRNA
PFE
Tags
GSK
Biotech
Benzinga
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
General
Alzheimer's disease
News
From
Benzinga
Moderna Rallies After Q4 Earnings: What 2 Analysts Have To Say About COVID-19 Stock
February 24, 2022
Tickers
MRNA
Tags
Mani Foroohar
Analyst Ratings
Trading Ideas
From
Benzinga
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
December 23, 2021
Tickers
MRK
PFE
Tags
Benzinga
Biotech
Geoffrey Porges
From
Benzinga
Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst
November 23, 2021
Tickers
AZN
BNTX
GSK
JNJ
Tags
Geoffrey Porges
Analyst Ratings
PFE
From
Benzinga
Why InflaRx Shares Are Ripping Higher Thursday
October 28, 2021
Tickers
IFRX
Tags
Analyst Ratings
HC Wainwright
Edward White
From
Benzinga
Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism
September 27, 2021
Tickers
GSK
SNY
Tags
Geoffrey Porges
Analyst Ratings
Benzinga
From
Benzinga
Why Did SVB Leerink Initiate Humana With Outperform?
September 27, 2021
Tickers
HUM
UNH
Tags
Whit Mayo
Benzinga
HUM
From
Benzinga
What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict
July 14, 2021
Tickers
AZN
FGEN
Tags
Biotech
FDA
Benzinga
From
Benzinga
Biohaven Rallies On Preliminary Nurtec Revenue Numbers: What Investors Need To Know
July 07, 2021
Tickers
BHVN
Tags
Movers
Nurtec
General
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.